Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 506 entries
View as:

Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00378768 Org: User:
Start: 11/30/05 End: 06/30/07 Due: 06/30/08

Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00244855 Org: User:
Start: 05/31/04 End: 08/29/11 Due: 08/29/12

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00002674 Org: User:
Start: 10/31/94 End: 03/31/00 Due: 03/31/01

Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00006244 Org: User:
Start: 02/29/00 End: 04/30/16 Due: 04/30/17

Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02584829 Org: User:
Start: 11/06/15 End: 12/18/18 Due: 12/18/19

Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00006241 Org: User:
Start: 03/31/00 End: 10/31/00 Due: 10/31/01

Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06094842 Org: User:
Start: 04/15/25 End: 03/15/28 Due: 03/15/29

Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT06034470 Org: User:
Start: 12/18/23 End: 12/31/27 Due: 12/31/28

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01427881 Org: User:
Start: 09/30/11 End: 07/31/15 Due: 07/31/16

Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01141959 Org: User:
Start: 05/31/10 End: 12/31/11 Due: 12/31/12

Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT01616056 Org: User:
Start: 06/30/12 End: 12/31/14 Due: 12/31/15

Hutchinson Smoking Prevention Project

Phase: N/A Priority: Normal
NCT ID: NCT00115869 Org: User:
Start: 09/30/84 End: 08/31/99 Due: 08/31/00

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00052520 Org: User:
Start: 09/30/02 End: 06/30/13 Due: 06/30/14

Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00073918 Org: User:
Start: 02/28/99 End: 10/02/11 Due: 10/02/12

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01525407 Org: User:
Start: 05/31/12 End: 02/29/16 Due: 02/28/17

MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife Women

Phase: N/A Priority: Normal
NCT ID: NCT00894543 Org: User:
Start: 07/31/09 End: 06/30/10 Due: 06/30/11

Avatar-Led Digital Therapeutic for Aiding Smoking Cessation in Sexual and Gender Minority Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT05847673 Org: User:
Start: 08/20/23 End: 06/13/24 Due: 06/13/25

Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00313625 Org: User:
Start: 09/30/05 End: - Due: -

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Phase: N/A Priority: Normal
NCT ID: NCT06817889 Org: User:
Start: 08/01/25 End: 11/30/27 Due: 11/30/28

Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05228249 Org: User:
Start: 04/30/23 End: 10/01/27 Due: 10/01/28

Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00244829 Org: User:
Start: 01/31/04 End: 08/31/07 Due: 08/31/08

Engaging School and Family in Navajo Gardening for Health

Phase: N/A Priority: Normal
NCT ID: NCT03775889 Org: User:
Start: 10/21/16 End: 06/13/18 Due: 06/13/19

Axatilimab for Sclerotic Chronic Graft-versus-Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT07011810 Org: User:
Start: 09/01/25 End: 02/10/30 Due: 02/10/31

Effect of Time-Restricted Eating During Cancer Treatment in Alaska Native Patients With Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06802172 Org: User:
Start: 05/31/25 End: 08/31/29 Due: 08/31/30

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Phase: N/A Priority: Normal
NCT ID: NCT00716066 Org: User:
Start: 06/30/08 End: 01/31/30 Due: 01/31/31